‘Vaccinated, Recovered or Dead’: Grim Warning as Europe Weighs Options Amid COVID-19 Surge 23/11/2021 Kerry Cullinan Other European countries may follow the example of Austria, which entered a nationwide lockdown on Monday, as COVID-19 cases continue to surge across the region. New COVID-19 cases increased by over 3,5 million in a single week, and deaths by over 50,000, according to the latest report from the European Centre for Disease Prevention and […] Continue reading -> Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> White House to Invest Billions of Dollars in Expanding US Vaccine Manufacturing – for This Pandemic and Next 17/11/2021 Elaine Ruth Fletcher In a bid to better respond to both domestic and global needs, as well as future threats, the Biden Administration plans to spend billions of dollars to expand US vaccine manufacturing capacity enabling production of 1 billion vaccine doses a year by mid-2022, two top White House officials told US media on Wednesday. The announcement […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
Independent Panel Co-Chairs Blast Slow Pace of Pandemic Reforms – Call for UN Summit After Next Week’s Special World Health Assembly 22/11/2021 Elaine Ruth Fletcher Six months after publication of their landmark report, Make it the Last Pandemic, the co-chairs of Independent Panel have re-entered the political fray over the slow pace of urgently needed reforms to vaccine equity, pandemic finance and countries’ legal obligations – that they say are required to end the COVID-19 pandemic and head off the […] Continue reading -> White House to Invest Billions of Dollars in Expanding US Vaccine Manufacturing – for This Pandemic and Next 17/11/2021 Elaine Ruth Fletcher In a bid to better respond to both domestic and global needs, as well as future threats, the Biden Administration plans to spend billions of dollars to expand US vaccine manufacturing capacity enabling production of 1 billion vaccine doses a year by mid-2022, two top White House officials told US media on Wednesday. The announcement […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
White House to Invest Billions of Dollars in Expanding US Vaccine Manufacturing – for This Pandemic and Next 17/11/2021 Elaine Ruth Fletcher In a bid to better respond to both domestic and global needs, as well as future threats, the Biden Administration plans to spend billions of dollars to expand US vaccine manufacturing capacity enabling production of 1 billion vaccine doses a year by mid-2022, two top White House officials told US media on Wednesday. The announcement […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution 03/11/2021 Raisa Santos The World Health Organization (WHO) has issued an emergency use listing (EUL) for India’s Covaxin, making it the eighth COVID-19 vaccine to be approved by the global body. “The emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts
As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts